GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Fatty Liver Disease/2D-SWE in MASLD
68

2D-SWE in MASLD

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated November 1, 2025

Two-dimensional shear wave elastography (2D-SWE) is a non-invasive imaging technique used to measure liver stiffness, which helps assess the severity of liver fibrosis. Liver fibrosis occurs when scar tissue builds up in the liver, often due to conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), a liver condition linked to obesity and metabolic issues. Early detection of fibrosis is critical, as advanced stages (like cirrhosis) increase the risk of complications such as liver failure or cancer.

2D-SWE works by sending ultrasound waves into the liver and measuring how quickly shear waves travel through the tissue. Stiffer liver tissue, often caused by fibrosis, results in faster wave propagation. This method is gaining attention because it provides accurate, reproducible results and is relatively easy to perform.

In MASLD, 2D-SWE is particularly useful because it overcomes some limitations of older techniques like vibration-controlled transient elastography (VCTE), which can be less accurate in obese patients. A recent meta-analysis has established standardized cutoff values for 2D-SWE to improve its diagnostic accuracy for different stages of fibrosis. By integrating 2D-SWE into clinical practice, healthcare providers can better identify high-risk MASLD patients, enabling earlier interventions and improved management of liver health.

Related Q&A

69

A new generation of non-invasive tests of liver fibrosis in MASLD

The new generation of non-invasive tests (NITs) for liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) are advanced diagnostic tools developed using machine learning and multitargeting approaches....

70

Targeting Hepatic Stellate cells in MASH

Targeting hepatic stellate cells (HSCs) in metabolic dysfunction-associated steatohepatitis (MASH) represents a promising therapeutic approach to prevent or reverse liver fibrosis, a key driver of disease progression. Below...

71

Plasma metabolomics prevents MASH related mortality

Plasma metabolomics, a branch of metabolomics focused on analyzing small molecules (metabolites) in blood plasma, plays a promising role in the prevention of metabolic dysfunction-associated steatohepatitis (MASH) and...

72

Exosome-related genes for MASLD-related HCC

Exosome-related genes have gained significant attention for their potential role in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) to hepatocellular carcinoma (HCC)....

73

Normal ALT, Liver Fibrosis and MASLD

The study you provided investigates the relationship between normal ALT (alanine transaminase) levels, liver fibrosis, and metabolic dysfunction-associated steatotic liver disease (MASLD). Here's a detailed breakdown of the...

74

Rapamycin alleviate intrahepatic inflammation in MASLD

Yes, rapamycin alleviates intrahepatic inflammation in metabolic dysfunction-associated steatotic liver disease (MASLD). According to the study, rapamycin's therapeutic effects are primarily mediated through its action on bone marrow-derived...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer